Analyst: WS Audiology will weather storm better than competitors
Sonova, Demant, and GN Hearing all suffered blows in the year’s second quarter, and all consequently downgraded financial expectations – but WSA might have navigated through the period unharmed, says an analyst, naming one division as the main contributing factor.
by albert-rønning andersson, translated by daniel pedersen
Last week, downgrades from some of the world’s biggest hearing aid manufacturers poured in – first came Sonova, then Demant, and lastly GN Hearing, all lowering their expectations for full-year performances after a second quarter marked by low consumer trust, sky-high inflation, and a new round of lockdowns in China.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
WS Audiology establishes business unit for the Americas
For subscribers
Demant plans to increase investments in China
For subscribers
